Search results for: “Pharmaceuticals”
-
Telix Pharmaceuticals to acquire QSAM Biosciences and its bone cancer therapy
•
MELBOURNE, AUSTRALIA: Telix Pharmaceuticals Limited, an Australian company that develops radiopharmaceuticals for cancer diagnosis and treatment, has announced…
-
Dr Howie McKibbon appointed CEO of Botanix Pharmaceuticals
•
SYDNEY, AUSTRALIA: Botanix Pharmaceuticals Limited (ASX: BOT), a company that specializes in clinical dermatology, has announced the promotion…
-
Astrocyte Pharmaceuticals raises $6 million to advance novel brain injury therapeutics
•
Astrocyte Pharmaceuticals, a company focused on clinical-stage drug discovery and development based in Cambridge, MA, with operations in…
-
EQT Funds and Luxinva S.A. to acquire Dechra Pharmaceuticals for £4.459 billion
•
LONDON, UK: Freya Bidco Limited has agreed to acquire entire issued, and to be issued, ordinary share capital…
-
Telix Pharmaceuticals to boost AI capabilities with acquisition of Dedicaid GmbH
•
MELBOURNE, AUSTRALIA: Melbourne-based Telix Pharmaceuticals Limited (ASX: TLX) has signed an agreement to acquire Dedicaid GmbH, a Vienna-based…
-
Indivior to acquire Opiant Pharmaceuticals for an upfront price of $145mn
•
RICHMOND, VA: Indivior PLC (LON: INDV) and Opiant Pharmaceuticals Inc. (NASDAQ: OPNT) have entered into a definitive agreement…
-
Telix Pharmaceuticals acquires Optimal Tracers
•
MELBOURNE, AUSTRALIA: Telix Pharmaceuticals has entered into an agreement with Sacramento-based Northern California PET Imaging Center (NCPIC) to acquire…
-
Dechra Pharmaceuticals acquired Med-Pharmex for $260 million
•
LONDON, UK: Dechra Pharmaceuticals (LSE: DPH) has acquired Med-Pharmex Inc. Med-Pharmex is a leading veterinary pharmaceutical manufacturer based…
-
MGC Pharmaceuticals acquires 40% equity stake in UK-based ZAM Software
•
LONDON, UK: MGC Pharmaceuticals has acquired a 40% equity stake in ZAM Software Limited, a UK incorporated entity…
-
BioPharma Credit to invest $325mn in Collegium Pharmaceuticals
•
LONDON, UK: BioPharma Credit (LSE: BPCR) t, through its fully owned subsidiary, together with BioPharma Credit Investments V…
-
AstraZeneca signs multi-billion dollar deal with Ionis Pharmaceuticals
•
LONDON, UK: AstraZeneca has closed a global development and commercialisation agreement with Ionis Pharmaceuticals, Inc. (Ionis) for eplontersen, formerly known as…
Stay Informed with the Latest News and Updates
- Contact Us
- London Stock Exchange
- Singapore Exchange
- Canadian Exchange
- Australian Exchange
- Oslo Bourse
- PSX
- Ratings
- Euronext
- MENA
- Nasdaq Nordic
- Wire
- Business & Finance
- Gadget Reviews
- About Us: A Comprehensive Financial News Database
All news and articles on NewsnReleases are based on press releases, corporate announcements and analysts’ reports issued to London Stock Exchange (LSE), Euronext, Singapore Exchange (SGX), Japan Stock Exchange (JPX), Dubai Financial Market (DFM), Saudi Stock Exchange (Tadawul), Qatar Stock Exchange (QSE), BSEIndia, Australia Stock Exchange etc.